Kaptopril Krka (Captopril)

Captopril blocks the angiotensin‑converting enzyme, preventing the formation of angiotensin II, a powerful vasoconstrictor. By reducing angiotensin II levels, blood vessels dilate, aldosterone secretion falls, and the body retains less sodium and water, leading to lower blood pressure and decreased cardiac workload.

The appropriate dose of Kaptopril Krka is individualized by the prescribing healthcare professional based on the patient’s condition, response, and renal function. Dosage adjustments may be required for elderly patients or those with impaired kidney function, and the prescriber will determine the exact regimen.

The safety of captopril in pregnancy has not been established, and it is generally avoided unless the potential benefit justifies the risk. Breastfeeding mothers should consult their physician, as captopril can be excreted in breast milk and may affect the infant.

To request Kaptopril Krka, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Captopril is one of several ACE inhibitors; it has a relatively short half‑life and may require multiple daily doses compared with longer‑acting agents like enalapril. Compared with angiotensin‑II receptor blockers (ARBs), captopril directly reduces angiotensin II production, which can lead to a higher incidence of cough but offers similar blood‑pressure‑lowering efficacy.

Store Kaptopril Krka at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, heat and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Kaptopril Krka is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescribing physician’s instructions regarding timing and whether to split doses throughout the day.

The most serious adverse events include angioedema, which can cause swelling of the face, lips, tongue or airway, and severe hypotension, especially after the first dose. Rarely, captopril can cause neutropenia or significant kidney function decline, requiring immediate medical attention.

Patients with a known hypersensitivity to captopril or any ACE inhibitor should avoid Kaptopril Krka. It is also contraindicated in individuals with a history of angioedema related to ACE‑inhibitor therapy, and caution is advised for those with severe renal impairment or hyperkalemia.